News &amp; Updates

Tocotrienol supplementation may help reduce levels of C-reactive protein (CRP) but not of interleukin (IL)-6, tumour necrosis factor-alpha (TNF-α) and malonaldehyde (MDA), a recent meta-analysis reports.

More evidence needed to understand anti-inflammatory, antioxidant effects of tocotrienols

Preservative-free latanoprost eye drops gentler on eyes

Preservative-free latanoprost eye drops induce a less severe stinging and burning sensation, leading to better adherence rates than its preserved counterpart, a recent study has found.

Preservative-free latanoprost eye drops gentler on eyes

What factors affect time to recovery in patients with drug-induced liver injury?

Serum bilirubin and alkaline phosphatase levels, along with the extent of drug metabolism, all affect the time to recover from drug-induced liver injury (DILI), a recent study has found.

What factors affect time to recovery in patients with drug-induced liver injury?

Oral vitamin C may reduce hyperuricemia

Oral vitamin C supplementation could lead to a reduction in serum uric acid (SUA) levels, a meta-analysis suggests.

Oral vitamin C may reduce hyperuricemia

Tirzepatide SURPASSes semaglutide for HbA1c reductions, weight loss

In patients with type 2 diabetes (T2D), once-weekly doses of the dual glucose-dependent insulinotropic polypeptide–GLP-1* receptor agonist tirzepatide for 40 weeks resulted in superior HbA_1c reductions compared with the GLP-1 receptor agonist semaglutide, according to results from the phase III SURPASS-2** trial presented at ADA 2021.

Tirzepatide SURPASSes semaglutide for HbA1c reductions, weight loss

Metabolite of gut microbiota may predict subclinical myocardial damage

Higher plasma levels of trimethylamine-N-oxide, a gut microbiota metabolite, seem to independently correlate with subclinical myocardial damage, a recent study has found.

Metabolite of gut microbiota may predict subclinical myocardial damage

NSAIDs, DMARDs, TNFis do not lower total hip/knee arthroplasty risk in AS/PsA patients

Any combination of nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), or tumuor necrosis factor inhibitors (TNFi) does not lead to a reduction in the likelihood of total hip or total knee arthroplasty (THA/TKA) among persons with ankylosing spondylitis (AS) or psoriatic arthritis (PsA), a US study has shown.

NSAIDs, DMARDs, TNFis do not lower total hip/knee arthroplasty risk in AS/PsA patients

Statins tied to adverse events, but risk does not outweigh benefits in preventing CVD

Use of statins is safe and leads to only a slight increase in the risk of self-reported muscle symptoms, liver dysfunction, renal insufficiency, and eye conditions in patients without a history of cardiovascular disease (CVD), according to a study.

Statins tied to adverse events, but risk does not outweigh benefits in preventing CVD

Rheumatoid arthritis with diabetes tied to worse functional status

Rheumatoid arthritis (RA) patients who also have diabetes mellitus (DM) are at risk of greater worsening or less improvement in functional status, reveals a study, suggesting that additional interventions may be needed to optimize treatment and management of other comorbidities.

Rheumatoid arthritis with diabetes tied to worse functional status

Wearable robots reveal true metabolic benefits in outdoor testing

Testing wearable robots for gait assistance in outdoor settings yields more representative data regarding their metabolic benefits, as opposed to treadmill testing, according to a recent study.

Wearable robots reveal true metabolic benefits in outdoor testing